Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
about
Glucagon secretion and signaling in the development of diabetesPancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the BlockMolecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistryIslet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetesSomatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic ratsAmelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in miceModulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network.Pancreatic immunoreactive somatostatin releaseDetermination of Optimal Sample Size for Quantification of β-Cell Area, Amyloid Area and β-Cell Apoptosis in Isolated IsletsThe fate of intraportally transplanted islets in diabetic rats. A morphologic and immunohistochemical study.Studies on a stable, mild diabetes induced by streptozotocin in ratsSpecific pancreatic beta-cell surface antigens recognized by a xenogenic antiserum.Glucose-induced insulin release depends on functional cooperation between islet cells.Identification of prosomatostatin in pancreatic islets.Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.Making insulin-deficient type 1 diabetic rodents thrive without insulin.Variations in rodent models of type 1 diabetes: islet morphology.Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide.Real-time imaging of the pancreas during development of diabetes.Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic ratsInsulin signaling in alpha cells modulates glucagon secretion in vivo.Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rateHistopathology of type 1 diabetes: old paradigms and new insights.Notch signaling in pancreatic endocrine cell and diabetes.Growth factor signalling in the regulation of α-cell fate.The regulation of pre- and post-maturational plasticity of mammalian islet cell mass.Role of cilia in normal pancreas function and in diseased states.Glucagon is the key factor in the development of diabetes.Delta Cell Hyperplasia in Adult Goto-Kakizaki (GK/MolTac) Diabetic Rats.The New Biology and Pharmacology of Glucagon.Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cell.Tumor necrosis factor-alpha modifies adhesion properties of rat islet B cells.Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs.Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas).Growth hormone release inhibitory hormone-like immunoreactivity in pancreas and gut in streptozotocin diabetes in the rat and response to insulin administration.Acute effects of alloxan- and streptozotocin-induced insulin deficiency on somatostatin and glucagon secretion by the perfused isolated rat pancreatico-duodenal preparation.Somatostatin, glucagon, and insulin secretion from perfused pancreas of BB rats.The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
P2860
Q21129250-8807B207-5DD0-4702-83DA-40F137873479Q26825393-898C4876-6C47-4341-8537-32A6393219B8Q33838626-2D4E6CCC-E396-4E4D-9D10-8BEBA576856BQ34016151-4027B13F-DB8F-42EE-ACEB-8C588FE94D83Q34234967-7412D32D-2183-4E5A-B877-E92B33B5B724Q34329427-7B983A5A-2220-492E-A899-31A2DAA47DABQ34526968-29E8F3A1-30C7-48D0-978D-A58581F02956Q34898915-12440E05-5E1C-415E-A214-244EBA1BC924Q35028312-6605543D-E1AB-4661-9D70-439E17F657FBQ35932787-2CEAADAC-18E6-43F3-BD9C-1EA6A3F439A6Q36058704-5AD059DD-63BF-4464-AE07-72B359CE3AAEQ36089632-FD76C80D-64C8-4425-8A68-BA34BD860EF2Q36209064-B7BED666-1A08-44F8-B2EC-D2F8B9CCA93EQ36323461-89AC0ABF-ADF3-4AB9-9AD7-C726B961A4F4Q36386477-3D7FDF67-C9A8-4152-9055-91936ED84C6EQ36579391-D6B843AA-67B9-4925-8DD5-9D0672D42EBAQ36893696-1B391E51-C1EE-41AF-814C-7EBEBB715D8DQ36898677-269FE99E-26EB-4DEF-BEC8-129F268C1C88Q37047088-499CBEBF-FD12-4F81-B00E-644127619AA3Q37084899-B2164D3B-51E3-45A4-A435-083D4E621EB3Q37176157-1215DAE1-91F3-4D13-88B2-21E637F02C2FQ37223046-10607EA7-FDB3-4F84-BA98-E382652CD4A5Q37412738-4968E995-84D5-4812-8C42-EC3969099658Q37425106-2E16DC38-49D9-424F-9BD7-857A07A99F5FQ37662799-15D3DD2E-E41A-4B4D-8D00-6F356D4DEBFFQ37913500-425F01CE-3ADB-4DF3-A56D-8EE72EAD2FA0Q38211528-EE5525C7-3E8F-48C5-84E1-588AC0ECBE43Q38214800-437A4568-3DF4-4B14-A731-4C9C00069169Q38817840-408B54D7-2BD3-4515-9CAE-AAE1BD53C22DQ38847076-1FC1FC56-70A8-44E3-8A29-415BE64C527BQ38919742-99F87561-7D74-4242-B8CE-66AA3BE47F5BQ39003819-410F4E0F-18FB-4B10-A812-F5017EC1D500Q40304400-EDAC69B2-FBC5-453B-9DE7-2F4BE0378CDAQ40809729-7BCF2827-905B-4CAC-80C6-3457ECBECBEEQ40863210-AD12D660-030F-425F-BA83-4170166E13BDQ41489444-A4725319-497B-44EC-977B-A7C11F6F959EQ42446003-01D04239-B715-45CE-B5E6-4D256F378597Q42447386-3A95A630-255A-459E-A806-55A5B40248D1Q42512998-5DD1016F-6406-4167-B65B-B71B8520523CQ43083184-D48CF798-8A7D-4A7C-A1BD-F6B1E9593FE7
P2860
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
description
1976 nî lūn-bûn
@nan
1976 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@ast
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@en
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@nl
type
label
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@ast
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@en
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@nl
prefLabel
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@ast
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@en
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@nl
P2093
P2860
P356
P1476
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
@en
P2093
F Malaisse-Lagae
M Ravazzola
P2860
P304
P356
10.1073/PNAS.73.4.1338
P407
P577
1976-04-01T00:00:00Z